Identification of SARS‐CoV‐2 Papain‐like Protease (PLpro) Inhibitors Using Combined Computational Approach

In the current pandemic, finding an effective drug to prevent or treat the infection is the highest priority. A rapid and safe approach to counteract COVID‐19 is in silico drug repurposing. The SARS‐CoV‐2 PLpro promotes viral replication and modulates the host immune system, resulting in inhibition...

Descripción completa

Detalles Bibliográficos
Autores principales: Sencanski, Milan, Perovic, Vladimir, Milicevic, Jelena, Todorovic, Tamara, Prodanovic, Radivoje, Veljkovic, Veljko, Paessler, Slobodan, Glisic, Sanja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805381/
https://www.ncbi.nlm.nih.gov/pubmed/35103413
http://dx.doi.org/10.1002/open.202100248

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805381/
https://www.ncbi.nlm.nih.gov/pubmed/35103413
http://dx.doi.org/10.1002/open.202100248

Ejemplares similares